Inovio Pharmaceuticals
Inovio develops DNA plasmid medicines delivered via its proprietary CELLECTRA device.
SCHEDULE 13GNov 16Latest SEC filing
Nov 10Latest story
November 2026
September 2026
August 2026
July 2026
Inovio develops DNA plasmid medicines delivered via its proprietary CELLECTRA device.
November 2026
September 2026
August 2026
July 2026